Preparation and Storage
推奨アッセイ手順
BD® CompBeads can be used as surrogates to assess fluorescence spillover (compensation). When fluorochrome conjugated antibodies are bound to BD® CompBeads, they have spectral properties very similar to cells. However, for some fluorochromes there can be small differences in spectral emissions compared to cells, resulting in spillover values that differ when compared to biological controls. It is strongly recommended that when using a reagent for the first time, users compare the spillover on cells and BD® CompBeads to ensure that BD® CompBeads are appropriate for your specific cellular application.
Product Notices
- Researchers should determine the optimal concentration of this reagent for their individual applications.
- The production process underwent stringent testing and validation to assure that it generates a high-quality conjugate with consistent performance and specific binding activity. However, verification testing has not been performed on all conjugate lots.
- Please refer to www.bdbiosciences.com/us/s/resources for technical protocols.
- An isotype control should be used at the same concentration as the antibody of interest.
- Caution: Sodium azide yields highly toxic hydrazoic acid under acidic conditions. Dilute azide compounds in running water before discarding to avoid accumulation of potentially explosive deposits in plumbing.
- CF™ is a trademark of Biotium, Inc.
- Please refer to http://regdocs.bd.com to access safety data sheets (SDS).
- For fluorochrome spectra and suitable instrument settings, please refer to our Multicolor Flow Cytometry web page at www.bdbiosciences.com/colors.
- Since applications vary, each investigator should titrate the reagent to obtain optimal results.
- Human donor specific background has been observed in relation to the presence of anti-polyethylene glycol (PEG) antibodies, developed as a result of certain vaccines containing PEG, including some COVID-19 vaccines. We recommend use of BD Horizon Brilliant™ Stain Buffer in your experiments to help mitigate potential background. For more information visit https://www.bdbiosciences.com/en-us/support/product-notices.
関連製品
The L272 monoclonal antibody specifically recognizes CD26 which is also known as Dipeptidyl peptidase IV (DPP IV), a serine protease. CD26 is a ~120 kDa type II transmembrane glycoprotein that is encoded by DPP4 and belongs to the DPP4 activity and/or structure homologue (DASH) protein family. It is associated with the binding of the TAT transactivating protein of the HIV. CD26 and CD45 act in a costimulatory fashion on T lymphocytes. Present on peripheral blood T lymphocytes, the CD26 antigen is upregulated on phytohemagglutinin (PHA) and concanavalin A (Con A)-stimulated peripheral blood mononuclear cells (PBMCs). The CD26 antigen is found on approximately 50% of CD4 and approximately 30% of CD8 cells. It is also found on some mature thymocytes, B cells, natural killer (NK) cells, monocytes, macrophages, epithelial cells, EBV transformed B-cell lines, and hairy cell leukemia. Absolute numbers of CD4+CD26+ and CD8+CD26+ cells are reported to be lower in HIV-positive individuals. The CD26-CD4+ cell appears to be a reservoir for HIV. CD26 bright CD4 lymphocytes are CD25+ and CD45RO+ memory T lymphocytes. The CD26 antigen can serve as a receptor for the coronavirus, MERS-CoV.
Development References (11)
-
Bleul CC, Wu L, Hoxie JA, Springer TA, Mackay CR. The HIV coreceptors CXCR4 and CCR5 are differentially expressed and regulated on human T lymphocytes.. Proc Natl Acad Sci U S A. 1997; 94(5):1925-1930. (Clone-specific: Flow cytometry). View Reference
-
Gutheil WG, Subramanyam M, Flentke GR, et al. Human immunodeficiency virus 1 Tat binds to dipeptidyl aminopeptidase IV (CD26): a possible mechanism for Tat's immunosuppressive activity.. Proc Natl Acad Sci USA. 1994; 91(14):6594-8. (Biology). View Reference
-
Lu G, Hu Y, Wang Q, et al. Molecular basis of binding between novel human coronavirus MERS-CoV and its receptor CD26.. Nature. 2013; 500(7461):227-31. (Biology). View Reference
-
Morimoto C, Kameoka J, Tanaka T, Schlossman S. Overview of CD26. In: Schlossman SF. Stuart F. Schlossman .. et al., ed. Leucocyte typing V : white cell differentiation antigens : proceedings of the fifth international workshop and conference held in Boston, USA, 3-7 November, 1993. Oxford: Oxford University Press; 1995:1105-1114.
-
Muñoz E, Blazquez MV, Madueño JA, Rubio G, Peña J. CD26 induces T-cell proliferation by tyrosine protein phosphorylation.. Immunology. 1992; 77(1):43-50. (Biology). View Reference
-
Plana M, Font J, Viñas O, Martorell J, Ingelmo M, Vives J. Responsiveness of T lymphocytes from systemic lupus erythematosus to signals provided through CD26 antigen.. Clin Immunol Immunopathol. 1994; 72(2):227-32. (Biology). View Reference
-
Stein H, Schwarting R, Niedobitek G. Cluster report: CD26. In: Knapp W. W. Knapp .. et al., ed. Leucocyte typing IV : white cell differentiation antigens. Oxford New York: Oxford University Press; 1989:412.
-
Ulmer AJ, Mattern T, Flad HD. Expression of CD26 (dipeptidyl peptidase IV) on memory and naive T lymphocytes.. Scand J Immunol. 1992; 35(5):551-9. (Biology). View Reference
-
Vanham G, Kestens L, De Meester I, et al. Decreased expression of the memory marker CD26 on both CD4+ and CD8+ T lymphocytes of HIV-infected subjects.. J Acquir Immune Defic Syndr. 1993; 6(7):749-57. (Biology). View Reference
-
Zola H. CD26. In: Zola H. Leukocyte and stromal cell molecules : the CD markers. Hoboken, N.J.: Wiley-Liss; 2007:81-82.
-
van Dongen JJ, Lhermitte L, Böttcher S, et al. EuroFlow antibody panels for standardized n-dimensional flow cytometric immunophenotyping of normal, reactive and malignant leukocytes. Leukemia. 2012; 26(9):1908-1975. (Clone-specific: Flow cytometry). View Reference
Please refer to Support Documents for Quality Certificates
Global - Refer to manufacturer's instructions for use and related User Manuals and Technical data sheets before using this products as described
Comparisons, where applicable, are made against older BD Technology, manual methods or are general performance claims. Comparisons are not made against non-BD technologies, unless otherwise noted.
For Research Use Only. Not for use in diagnostic or therapeutic procedures.